9
Participants
Start Date
November 30, 2007
Primary Completion Date
September 30, 2009
Study Completion Date
March 31, 2010
Lapatinib
Small molecule tyrosine kinase inhibitor
Capecitabine
Chemotherapy
Docetaxel
Chemotherapy
nab-Paclitaxel
Chemotherapy
GSK Investigational Site, New York
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Baltimore
GSK Investigational Site, Fairfax
GSK Investigational Site, Abingdon
GSK Investigational Site, Sumter
GSK Investigational Site, Lawrenceville
GSK Investigational Site, Atlanta
GSK Investigational Site, Orlando
GSK Investigational Site, Hollywood
GSK Investigational Site, Fort Lauderdale
GSK Investigational Site, Tupelo
GSK Investigational Site, Indianapolis
GSK Investigational Site, Minneapolis
GSK Investigational Site, Zion
GSK Investigational Site, Metairie
GSK Investigational Site, New Orleans
GSK Investigational Site, Hot Springs
GSK Investigational Site, San Antonio
GSK Investigational Site, Austin
GSK Investigational Site, Ogden
GSK Investigational Site, Long Beach
GSK Investigational Site, Burbank
GSK Investigational Site, Highland
GSK Investigational Site, Anaheim
GSK Investigational Site, Sacramento
GSK Investigational Site, Voorhees Township
GSK Investigational Site, Albuquerque
Lead Sponsor
GlaxoSmithKline
INDUSTRY